Personalized home activity program for people with mild-to-moderate dementia after hospital discharge
Official title: Construction and Efficacy Evaluation of a Dyadic Personalized Home-Based Activity Intervention Program for Patients Discharged With Mild to Moderate Dementia and Behavioral and Psychological Symptoms
Run by Fujian Medical University · NCT07081750 · Data updated 2026-11-12
This will try to see if a tailored home activity program, together with training for family caregivers, reduces agitation and other behavioral symptoms in people aged 60+ with mild-to-moderate dementia after they leave the hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 55 (estimated) |
| Sponsor | Fujian Medical University Academic / other |
| Locations | 1 site (Fujian, Fuzhou) |
| Status | Recruiting |
| Started | July 20, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | May 11, 2026 |
| Trial ID | NCT07081750 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are home-dwelling adults aged 60 or older with ICD-10 dementia and a Clinical Dementia Rating of 1–2 who have at least one recent neuropsychiatric symptom and a family caregiver willing to be trained and provide home care.
✕Probably not a fit
Patients without a reliable, trainable family caregiver, those with severe dementia or lacking basic verbal communication, or those not discharged to home are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will compare patients receiving routine post-discharge care to those given a dyadic personalized home-based activity program. In the hospital, clinicians tailor an individualized activity plan and train the primary family caregiver while providing activity resources and support. After discharge, the trained caregiver delivers the intervention at home with ongoing professional support and follow-up. The main outcome is change in behavioral and psychological symptoms of dementia measured using standard instruments such as the Neuropsychiatric Inventory.
Why it matters
Potential benefit: If successful, the program could reduce behavioral and psychological symptoms, improve daily engagement, and lower caregiver distress to support safer, more comfortable home living.
How similar studies have gone: Caregiver-delivered, home-based activity programs have shown promise in reducing BPSD in prior studies, but dyadic personalized interventions remain moderately tested and need further replication.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria Patients * Be aged ≥ 60 years; * Have a diagnosis of dementia according to ICD-10 criteria, with a Clinical Dementia Rating (CDR) score of 1-2 (mild-to-moderate stage); * Retain basic verbal communication ability; * Present at least one neuropsychiatric symptom (a score ≥ 1 on any single item) within the past month, as evaluated by the Neuropsychiatric Inventory (NPI); * Be medically fit for hospital discharge and scheduled to receive home care post-discharge; * Be willing to participate in this study and provide written informed consent. Family Caregivers * Be aged ≥ 18 years; * Have kinship with the patient (e.g., spouse, children, siblings, etc.); * Undertake primary care responsibilities on an unpaid, non-professional basis, and have the longest average daily care hours among all family caregivers; * Be willing to assume continuous home care responsibilities for at least 3 months post-discharge; * Have intact verbal communication skills; * Possess basic proficiency in operating the WeChat application (a widely used social communication application in China), including independently sending and receiving messages, as well as making voice and video calls; * Be willing to participate in this study and provide written informed consent. Exclusion Criteria Patients * Have severe somatic diseases (e.g., malignant tumors, heart failure, physical disabilities) or severe psychiatric disorders; * Have severe visual or hearing impairment; * Have dementia secondary to the following conditions: central nervous system diseases (e.g., encephalitis, brain tumors, epilepsy, multiple sclerosis, Parkinson's disease), nutritional and metabolic disorders (e.g., thyroid dysfunction, vitamin B12 or folate deficiency), substance or alcohol dependence, and other potential causes of secondary dementia; * Suffer from severe physical or mental disorders, extreme debilitation, long-term bedridden status, end-stage disease with a life expectancy of less than six months, or be unable to cooperate with or tolerate the study intervention; * Be enrolled in any other clinical research that may interfere with the outcomes of this study. Family Caregivers * Have severe somatic diseases (e.g., malignant tumors, heart failure, physical disabilities) or severe psychiatric disorders; * Have severe visual or hearing impairment; * Be enrolled in any other clinical research that may interfere with the outcomes of this study.
Where it's running
-
Union Hospital Affiliated to Fujian Medical University
Fujian, Fuzhou, China Recruiting
Study contacts
- Study coordinator: Xiaozhen Fu
- Email: 15160301901@163.com
- Phone: 15160301901
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Doll Therapy for Apathy and Daily Living in Older Adults with Dementia
This study tests whether doll therapy helps reduce apathy and improves starting daily activities in older adults with dementia.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.